Copyright
©The Author(s) 2026.
World J Clin Cases. Jan 26, 2026; 14(3): 114521
Published online Jan 26, 2026. doi: 10.12998/wjcc.v14.i3.114521
Published online Jan 26, 2026. doi: 10.12998/wjcc.v14.i3.114521
Table 1 Sphenopalatine ganglion blockade techniques
| Technique | Ref. | Approach | Description | Key advantages | Key limitations/considerations |
| Trans nasal | Schaffer et al[13], 2015 | Topical | A cotton-tipped applicator, catheter, or atomizer is used to apply a local anesthetic (e.g., lidocaine) to the nasal mucosa; an anesthetic is applied to the posterior pharyngeal wall mucosa; the goal is to diffuse the medication to the underlying sphenopalatine ganglion (SPG) | It is noninvasive and simple; quick to perform at the bedside; there is a low risk of serious complications; easily repeatable | Drug diffusion is inconsistent; shorter duration of the effect; the anesthetic dose is not precisely controlled; uncomfortable for patients |
| Transoral | Piagkou et al[11], 2012 | Invasive | The needle is advanced through the hard palatine’s greater palatine foramen; the needle enters the pterygopalatine fossa; local anesthetic is injected directly into SPG; it is often performed under fluoroscopic guidance | This allows for the precise injection of a known volume; provides a more consistent and prolonged effect | Invasive: Risk of vascular injury and hematoma; risk of infection |
| Suprazygomati | Alseoudy et al[9], 2024 | Invasive and ultrasound-guided | The needle is advanced superior to the zygomatic arch; the needle is guided to the pterygopalatine fossa to deliver anesthesia; the procedure is performed under real-time ultrasonographic guidance | Real-time visualization can improve the accuracy and safety of the procedure; it avoids radiation exposure | This requires significant ultrasound expertise and equipment; this is technically more challenging; risk of orbital injury |
| Infrazygomatic | Anthony Cometa et al[14], 2021 | Invasive and fluoroscopy-guided | The needle is advanced inferior to the zygomatic arch through the masseter muscle; fluoroscopic imaging is used to guide the needle into the pterygopalatine fossa; imaging confirmed correct needle placement before anesthetic administration | Direct visualization of the needle position using fluoroscopy; it confirms accurate needle placement | It involves radiation exposure for both patients and operators; it is invasive and carries the risk of vascular injury and hematoma; it can damage the surrounding nerves |
Table 2 Chronological summary of key systematic reviews and meta-analyses on postdural puncture headache management
| Ref. | Type of review | Key focus | Included studies (n) | Key interventions | Main conclusion and finding |
| Basurto Ona et al[15], 2015 | Cochrane review | Pharmacological treatment | 13 RCTs | Caffeine, gabapentin, and theophylline | Evidence for the benefits of these drugs is limited owing to small, biased studies, although some drugs have shown promise |
| Barati-Boldaji et al[16], 2023 | Meta-analysis | Aminophylline/theophylline | 15 studies | Aminophylline, theophylline | They showed potential for treatment but not for prevention |
| Chang et al[17], 2021 | Meta-analysis | GON block (treatment) | 7 studies | Greater occipital nerve block | GONB is effective for short-term PDPH pain relief |
| Giaccari et al[18], 2021 | Systematic review | Nerve blocks (treatment) | 19 studies | SPG block, GONB, LON block | Peripheral nerve blocks are promising and safe options |
| Zhao et al[19], 2023 | Bayesian network meta analysis | Pharmacological prevention | 22 RCTs | Propofol, ondansetron, and amin | Propofol, ondansetron, and aminophylline were the most effective in reducing PDPH incidence |
| Dwivedi et al[20], 2023 | Meta-analysis | SPG block (treatment) | 9 RCTs | Trans-nasal SPG Block | The SPG block was effective for immediate pain relief compared to the controls, but the effect was short-lived |
| Alatni et al[3], 2024 | Systematic review | Multi-modal (treatment and prevention) | 38 studies | Pharmacologic, nerve blocks, EBP | Various effective strategies were summarized, and EBP was affirmed as the gold standard |
Table 3 Detailed efficacy and findings from included reviews
| Ref. | Key focus | Main conclusion and finding | Key interventions with positive outcomes | Key interventions with no significant effect |
| Basurto Ona et al[15], 2015 | Pharmacological treatment | However, evidence for the benefits was limited due to the small sample size and bias in the studies; some drugs were promising in reducing pain scores | Caffeine: Reduced PDPH persistence compared to placebo; gabapentin: Better VAS scores vs placebo/ergotamine; hydrocortisone: Better VAS scores than conventional treatment/placebo; theophylline: Better VAS scores than acetaminophen/conservative treatment | Sumatriptan and ACTH: No relevant effect on pain scores |
| Barati-Boldaji et al[16], 2023 | Aminophylline/theophylline (Tx and prevention) | Therapeutic use significantly reduced pain scores (moderate evidence); prophylactic use did not significantly reduce the PDPH risk (very low evidence) | Aminophylline/theophylline: Effective for pain relief compared to placebo or conventional therapy | Aminophylline: Not effective for prevention |
| Chang et al[17], 2021 | GON block (treatment) | GONB was effective for short-term pain relief at 1, 6, and 24 hours and reduced intervention failure | Greater occipital nerve block (GONB): Effective for pain relief; steroid co-administration may extend this effect | N/A |
| Giaccari et al[18], 2021 | Nerve blocks (treatment) | Peripheral nerve blocks (SPG, GON, and LON) were effective, safe, and significantly reduced pain scores | SPG, GON, LON blocks: Effective analgesic options | N/A |
| Zhao et al[19], 2023 | Pharmacological prevention (obstetric) | Propofol, ondansetron, and aminophylline were the most effective in reducing PDPH incidence; propofol and ondansetron also reduced PONV | Propofol (PPF), ondansetron (OND), and aminophylline (AMP) are effective; gabapentin/pregabalin (GBP/PGB): Effective at 48 hours | Dexamethasone, hydrocortisone: No superiority over placebo; no therapy reduced headache severity |
| Dwivedi et al[20], 2023 | SPG block (treatment) | SPG block was effective for immediate, short-term pain relief (up to 6 hours) vs conservative treatment and lignocaine puffs | Transnasal SPG block: Effective for short-term relief | It was not superior to the sham or GON blocks; effects were not sustained beyond 6 hours |
| Alatni et al[3], 2024 | Multi-modal (Tx and prevention) | Various effective strategies have been summarized, and EBP remains the gold standard; nerve blocks are effective and less invasive | Oral pregabalin and intravenous (IV) aminophylline are effective for the treatment and prevention of migraine headaches; IV Mannitol, IV hydrocortisone, neostigmine + atropine, SPG/GON blocks: Effective; fibrin glue, smaller needles: Effective prevention; EBP: Gold standard | Neuraxial morphine, epidural dexamethasone: Questionable for prevention |
Table 4 Consolidated efficacy summary of major postdural puncture headache interventions
| Ref. | Intervention | Primary use | Efficacy for PDPH prevention | Efficacy for PDPH treatment | Key findings and notes | Common/notable side effects |
| Alatni et al[3], 2024; Barati-Boldaji et al[16], 2023 | Aminophylline/theophylline | Treatment and prevention | Mixed (not recommended): A meta-analysis found no significant benefit of prophylaxis (very low evidence) | Effective (recommended): Significantly reduced pain scores (moderate evidence); this effect is enhanced when combined with dexamethasone | Considered a primary pharmacological option for treating established PDPH; the efficacy of prevention is not well supported | No significant adverse events were reported in the studies |
| Basurto Ona et al[15], 2015 | Caffeine | Treatment | It is not typically used for prevention | Effective (recommended): Reduces the persistence of PDPH and the need for rescue interventions compared to placebo | A classic and well-established treatment for PDPH | Well tolerated; no major side effects were reported in the review |
| Alatni et al[3], 2024; Basurto Ona et al[15], 2015; Zhao et al[19], 2023 | Gabapentin/pregabalin | Treatment and prevention | Effective (potential): Pregabalin has a preventive effect; gabapentin/pregabalin reduced incidence at 48 hours | Effective (recommended): Superior to placebo and ergotamine + caffeine in reducing pain scores over several days | Oral pregabalin has been highlighted as being particularly effective for both treatment and prevention | Generally well tolerated; sedation was mentioned but not quantitatively synthesized |
| Zhao et al[19], 2023 | Ondansetron (OND) | Prevention | Effective (recommended): Significantly reduces the cumulative incidence of PDPH | Not assessed for treatment in these reviews | It also significantly reduces the incidence of postoperative nausea and vomiting (PONV) | It may induce migraine headaches in patients with a history of migraine (case reports) |
| Zhao et al[19], 2023 | Propofol (PPF) | Prevention | Most effective (recommended): Ranked as the most effective prophylactic drug for reducing incidence | Not assessed for treatment in these reviews | Also significantly reduces the incidence of postoperative nausea and vomiting (PONV) | Sedation, diplopia, and tinnitus were mentioned in individual studies |
| Basurto Ona et al[15], 2015; Zhao et al[19], 2023 | Corticosteroids (dexamethasone, hydrocortisone) | Treatment and prevention | Not effective: Dexamethasone did not show superiority in prevention (hydrocortisone did not show any significant prophylactic effects) | Effective for treatment: Hydrocortisone (IV) combined with conventional treatment led to better pain scores | Hydrocortisone is effective for treatment but not for prevention; the utility of dexamethasone remains questionable | No clinically significant adverse events were reported |
| Chang et al[17], 2021 | Greater occipital nerve block (GONB) | Treatment | N/A | Effective (recommended): Provides significant short-term pain relief (1 hour, 6 hours, 24 hours) and reduces intervention failure | A feasible, less invasive alternative to EBP; steroid coadministration may prolong analgesic effects | No major adverse events were reported. Minor local discomfort |
| Dwivedi et al[20], 2023 | Sphenopalatine ganglion block (SPGB) | Treatment | N/A | Effective (short-term): Superior to conservative care for immediate pain relief (up to 6 hours); not superior to sham or GONB | The effects are immediate but short-lived; it was not superior to the other nerve blocks | Nasal discomfort, throat numbness, and unpleasant taste (minor and transient) |
| Alatni et al[3], 2024 | Epidural blood patch (EBP) | Treatment | N/A | Highly effective (gold standard): The ultimate solution for patients failing medical therapy | It rapidly decreases headache intensity; approximately 20% may require a second procedure; it is more invasive than pharmacological or nerve block options | Risks associated with neuraxial procedures (e.g., infection, repeat dural puncture) |
| Alatni et al[3], 2024 | Fibrin glue | Prevention | Effective (promising): Significantly reduced PDPH incidence and duration in the reviewed evidence | N/A | A novel preventive strategy has been noted for its promising safety and affordability | Not explicitly stated; however, the reviewed evidence noted a good safety profile |
- Citation: Mahanty PR, Sen B, Anand R, Nag DS, Pahadi N, Lodh D, Upadhyaya T. Sphenopalatine ganglion block for postdural puncture headache: A review of current evidence. World J Clin Cases 2026; 14(3): 114521
- URL: https://www.wjgnet.com/2307-8960/full/v14/i3/114521.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v14.i3.114521
